CRS and HIPEC: Best model of antifragility in surgical oncology.

Autor:	Souadka A; Surgical Oncology Department, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco., Essangri H; Surgical Oncology Department, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco., El Bahaoui N; Surgical Oncology Department, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco., Ghannam A; Intensive Care Department, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco., El Ahmadi B; Intensive Care Department, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco., Benkabbou A; Surgical Oncology Department, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco., Majbar MA; Surgical Oncology Department, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco., El Khannoussi B; Anatomopathology Department, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco., Abahssain H; Medical Oncology Department, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco., Mohsine R; Surgical Oncology Department, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco., Belkhadir ZH; Intensive Care Department, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco.
Jazyk:	angličtina
Zdroj:	Journal of surgical oncology [J Surg Oncol] 2022 Aug; Vol. 126 (2), pp. 396-397. Date of Electronic Publication: 2022 Apr 23.
DOI:	10.1002/jso.26882
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text